MX389613B - Uso de compuesto de carbamato para prevenir o tratar neuralgia trigeminal. - Google Patents

Uso de compuesto de carbamato para prevenir o tratar neuralgia trigeminal.

Info

Publication number
MX389613B
MX389613B MX2018014081A MX2018014081A MX389613B MX 389613 B MX389613 B MX 389613B MX 2018014081 A MX2018014081 A MX 2018014081A MX 2018014081 A MX2018014081 A MX 2018014081A MX 389613 B MX389613 B MX 389613B
Authority
MX
Mexico
Prior art keywords
trigeminal neuralgia
carbamate compound
prevent
pharmaceutical composition
treat trigeminal
Prior art date
Application number
MX2018014081A
Other languages
English (en)
Spanish (es)
Other versions
MX2018014081A (es
Inventor
Han Ju Yi
Min Jae Jo
Sun Gwan Hwang
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Publication of MX2018014081A publication Critical patent/MX2018014081A/es
Publication of MX389613B publication Critical patent/MX389613B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2018014081A 2016-05-19 2017-05-18 Uso de compuesto de carbamato para prevenir o tratar neuralgia trigeminal. MX389613B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160061386 2016-05-19
PCT/KR2017/005172 WO2017200317A1 (ko) 2016-05-19 2017-05-18 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Publications (2)

Publication Number Publication Date
MX2018014081A MX2018014081A (es) 2019-09-02
MX389613B true MX389613B (es) 2025-03-20

Family

ID=60325324

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018014081A MX389613B (es) 2016-05-19 2017-05-18 Uso de compuesto de carbamato para prevenir o tratar neuralgia trigeminal.

Country Status (14)

Country Link
US (2) US11207295B2 (enExample)
EP (1) EP3459542B1 (enExample)
JP (1) JP6960415B2 (enExample)
KR (1) KR102421013B1 (enExample)
CN (1) CN109310669B (enExample)
AU (1) AU2017267160B2 (enExample)
CA (1) CA3024284C (enExample)
DK (1) DK3459542T3 (enExample)
ES (1) ES2887338T3 (enExample)
MX (1) MX389613B (enExample)
PL (1) PL3459542T3 (enExample)
PT (1) PT3459542T (enExample)
RU (1) RU2751504C2 (enExample)
WO (1) WO2017200317A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3035674T3 (en) 2016-12-14 2025-09-08 Sk Biopharmaceuticals Co Ltd Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease
IL281559B2 (en) * 2018-09-21 2025-06-01 Sk Biopharmaceuticals Co Ltd (r)-1-phenyl-2-tetrazolyl ethyl carbamate derivatives and formulations comprising same for use in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder
KR20210062029A (ko) 2018-10-19 2021-05-28 에스케이바이오팜 주식회사 카바메이트 화합물의 당뇨병성 말초 신경병증 또는 화학요법 유발 말초 신경병증의 예방, 완화 또는 치료를 위한 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) * 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
DE2628420A1 (de) * 1976-06-24 1978-01-05 Bayer Ag 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide
EP0959882A4 (en) * 1996-12-31 2001-12-05 N-BONDED UREAUTIES AND CARBAMATES OF HETEROCYCLIC THIOESTERS
MXPA03007721A (es) * 2001-02-27 2004-11-12 Johnson & Johnson Compuesto de carbamato para su uso en el tratamiento del dolor.
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
JP4227121B2 (ja) * 2005-06-08 2009-02-18 独立行政法人科学技術振興機構 神経因性疼痛治療剤
AU2009348523B2 (en) * 2009-06-22 2015-02-26 Sk Biopharmaceuticals Co., Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
US8404461B2 (en) 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
KR20140009244A (ko) * 2010-11-11 2014-01-22 애크런 몰레큘스 게엠베하 통증 치료용 화합물 및 방법
SI3054950T1 (sl) * 2014-05-09 2017-12-29 Tecnimede-Sociedade Tecnico-Medicinal, S.A. (r)-pirindol in njegove farmacevtsko sprejemljive soli za uporabo v medicini

Also Published As

Publication number Publication date
BR112018073556A2 (pt) 2019-03-19
MX2018014081A (es) 2019-09-02
AU2017267160A1 (en) 2018-12-13
CN109310669A (zh) 2019-02-05
EP3459542A4 (en) 2020-01-08
US12611395B2 (en) 2026-04-28
KR20170131241A (ko) 2017-11-29
CN109310669B (zh) 2022-02-22
ES2887338T3 (es) 2021-12-22
RU2018144784A (ru) 2020-06-19
CA3024284A1 (en) 2017-11-23
EP3459542B1 (en) 2021-06-30
US20190175555A1 (en) 2019-06-13
RU2018144784A3 (enExample) 2020-08-11
JP2019516722A (ja) 2019-06-20
US11207295B2 (en) 2021-12-28
KR102421013B1 (ko) 2022-07-14
US20220087976A1 (en) 2022-03-24
DK3459542T3 (da) 2021-09-13
EP3459542A1 (en) 2019-03-27
PL3459542T3 (pl) 2021-12-27
CA3024284C (en) 2024-01-23
RU2751504C2 (ru) 2021-07-14
AU2017267160B2 (en) 2022-11-10
PT3459542T (pt) 2021-08-24
WO2017200317A1 (ko) 2017-11-23
JP6960415B2 (ja) 2021-11-05

Similar Documents

Publication Publication Date Title
MX2023000025A (es) Inhibidores de la quinasa progenitora hematopoyética 1 y usos de estos.
MX2021006011A (es) Un inhibidor de la quinasa aurora a para su uso en el tratamiento del neuroblastoma.
NZ752250A (en) Compounds, devices, and uses thereof
BR112018070602A2 (pt) composto, composição farmacêutica, uso do composto, e, método para tratar uma doença ou distúrbio
MX394245B (es) Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia.
SA520411524B1 (ar) مركبات تنشيط القسيم العضلي ثنائي الأميد واستخداماتها
MX2021014531A (es) Compuestos de aminopurina sustituida, composiciones del mismo, y metodos de tratamiento con los mismos.
JOP20190186A1 (ar) مركب كينازولين
BR112017003054A2 (pt) compostos de aminopirimidinila como inibidores de jak
SA518400356B1 (ar) مثبطات الأرجيناز واستخداماتها العلاجية
EA201891203A1 (ru) Гетероциклические соединения в качестве иммуномодуляторов
WO2015200680A8 (en) Prmt5 inhibitors and uses thereof
MY196576A (en) Amino Pyrimidine SSAO Inhibitors
PH12019501690A1 (en) Pyrimidine compound and pharmaceutical use thereof
MX388175B (es) Compuestos terapéuticos y métodos para utilizarlos
MX2020008678A (es) Metodos de uso para derivados de benzotriazol trisustituidos.
HK1254954A1 (zh) Lpt-723和免疫检查点抑制剂组合物及其治疗方法
JOP20190053A1 (ar) مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط
PH12017501130A1 (en) Indenyl compounds, pharmaceutical compositions, and medical uses thereof
SV2018005702A (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cancer
EA035519B9 (ru) 1,3,4-тиадиазольные соединения и их применение в лечении рака
EA201891240A1 (ru) 1,3,4-тиадиазольные соединения и их применение в лечении рака
MX2022006229A (es) Composiciones y metodos para el tratamiento de resistencia a la insulina.
MX2018014081A (es) Uso de compuesto de carbamato para prevenir o tratar neuralgia trigeminal.
MX381323B (es) Derivado de imidazopirimidina e imidazotriazina, y composición farmacéutica que lo comprende.